(2023) 10:e2203973
We highlight several often-neglected additional therapeutic advantages of GLP-1 RAs, such as their ability to decrease neuroinflammation and immune senescence, along with the potential for GLP-1 RAs to help lower vascular stiffness and combat sarcopenia, both of which are major factors affecting mobility, resilience, and overall health in older individuals
Bu nedenle C vitamini ve L-karnitin birlikte alnmas nerilir
Project 3: GLP-1R/GIPR agonists in promoting gastroenteropancreatic (GEP) NET progression Project Co-Leaders: Po Hien Ear, PhD (Basic Co-Leader) Joseph Dillon, MD (Clinical Co-Leader) James Howe, MD (Clinical Co-Leader) This timely investigation will define the role and impact of increasingly used obesity and diabetes drugs, GLP-1 and GIP receptor agonists like Ozempic, on GEPNET growth
For more detailed information on how semaglutide supports sustainable weight loss, you can check this resource for further reading
Conclusion In the SUSTAIN 8 substudy, the changes in body composition between semaglutide and canagliflozin were not significantly different in participants with uncontrolled type 2 diabetes on stable-dose metformin therapy
